About Penta
Who we are
Diversity and Inclusion
Penta ID Network
Penta Foundation Italy
Penta ID Innovation
Annual reports
Our Activities
News & Events
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Call for services
Brighter Future Award
Archivio
Pharmacokinetics, safety and transplacental passage of rilpivirine in pregnancy: two cases
Adherence to antiretroviral therapy in pregnancy and during the first year post-partum in HIV-positive women in Ukraine
Successful private-public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines
Effective exposure to atazanavir during pregnancy, regardless of tenofovir use
A comparison of the pharmacokinetics of raltegravir during pregnancy and postpartum
Low darunavir exposure during pregnancy with 800/100mg darunavir/r QD dosing
Uptake and outcomes of HCV treatment in children and young adults with HIV/HCV co-infection in Europe
Children living with HIV in Ukraine: response to antiretroviral therapy (ART) and duration of first-line regimens
Using CD4 Percentage and Age to Optimize Pediatric Antiretroviral Therapy Initiation
Post-licensing safety of fosamprenavir in HIV-infected children in Europe.
Pharmacokinetics of Pediatric Lopinavir/Ritonavir Tablets in Children When Administered Twice Daily According to FDA weight bands.
HIV-1 resistance after randomized virologic switch at 1,000 or 30,000 c/ml in children.
Moving on up: tracking young people with perinatal HIV as they transition to adult care in Europe
Double dosing of ritonavir in twice-daily darunavir-containing regimens: an example of a lack of appropriate formulations in paediatrics
Increasing abacavir use in HIV-1-infected pregnant women in Europe: effectiveness and safety data